Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Platinum-Based Delayed-Phase Chemotherapy-Induced Nausea and Vomiting: A Meta-Analysis. [PDF]
Gong W +5 more
europepmc +1 more source
Chemotherapy-induced nausea and vomiting symptom experience in patients with non-small-cell lung cancer: A qualitative study. [PDF]
Cheng J +5 more
europepmc +1 more source
Improving the Appropriate Prescribing of Olanzapine for Chemotherapy-Induced Nausea and Vomiting: A Quality Improvement Initiative for the Outpatient Oncology Practice. [PDF]
Gennette RL +6 more
europepmc +1 more source
Efficacy of olanzapine for prophylaxis of delayed chemotherapy-induced nausea and vomiting in patients with breast cancer receiving dose-dense AC with a steroid-sparing regimen: a single-center pilot study. [PDF]
Tada M +6 more
europepmc +1 more source
Development of a large language model-based knowledge graph for chemotherapy-induced nausea and vomiting in breast cancer and its implications for nursing. [PDF]
Liu Y, Chen J, Lin X, Song J, Chen S.
europepmc +1 more source
Factors affecting chemotherapy-induced nausea and vomiting in patients with lung squamous cell carcinoma. [PDF]
Wang J.
europepmc +1 more source
Medicinal Plants for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review of Antiemetic, Chemosensitizing, and Immunomodulatory Mechanisms. [PDF]
Sun X, Nie F, Sun J, Zhang J, Wang Y.
europepmc +1 more source
Netupitant/palonosetron is effective for preventing chemotherapy-induced nausea and vomiting in high-dose melphalan conditioning before autologous stem cell transplantation: A real-world analysis. [PDF]
Cao LQ +15 more
europepmc +1 more source
The effect of Citrus aurantium inhalation aromatherapy on chemotherapy-induced nausea and vomiting in breast cancer patients: a randomized controlled trial. [PDF]
Tabei P +4 more
europepmc +1 more source
Expert Consensus Guidance on the Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective. [PDF]
Dhabhar B +10 more
europepmc +1 more source

